Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Vismodegib drug shows no addded benefit
.
Show all posts
Showing posts with label
Vismodegib drug shows no addded benefit
.
Show all posts
Friday, November 18, 2016
Vismodegib drug shows no addded benefit in advanced or symptomatic metastatic BCC patients
›
Vismodegib (trade name: Erivedge) has already been approved since 2013 for the treatment of patients with locally advanced basal ce...
›
Home
View web version
